Australia
# |
Name |
EBITDA |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 4.73 B
|
June 30, 2024 | USD 173.13 | 0.11% |
|
Australia |
|
2 |
USD 1.20 B
|
June 30, 2024 | USD 21.27 | 2.57% |
|
Australia |
|
3 |
USD 1.11 B
|
June 30, 2024 | USD 17.28 | 1.26% |
|
Australia |
|
4 |
USD 542.48 M
|
June 30, 2024 | USD 2.35 | 0.77% |
|
Australia |
|
5 |
USD 396.68 M
|
June 30, 2024 | USD 20.43 | 1.47% |
|
Australia |
|
6 |
USD 202.30 M
|
June 30, 2024 | USD 21.11 | 1.40% |
|
Australia |
|
7 |
USD 127.65 M
|
June 30, 2024 | USD 3.89 | 3.70% |
|
Australia |
|
8 |
USD 113.12 M
|
June 30, 2024 | USD 2.14 | 0.82% |
|
Australia |
|
9 |
USD 80.52 M
|
June 30, 2024 | USD 157.25 | 0.24% |
|
Australia |
|
10 |
USD 39.42 M
|
June 30, 2024 | USD 0.84 | -1.22% |
|
Australia |
|
11 |
USD 37.52 M
|
June 30, 2024 | USD 7.32 | 6.16% |
|
Australia |
|
12 |
USD 34.97 M
|
Jan. 31, 2024 | USD 1.81 | -0.44% |
|
Australia |
|
13 |
USD 27.66 M
|
June 30, 2024 | USD 1.21 | 0.76% |
|
Australia |
|
14 |
USD 15.64 M
|
Dec. 31, 2023 | USD 15.47 | 4.25% |
|
Australia |
|
15 |
USD 14.48 M
|
June 30, 2024 | USD 2.01 | -0.68% |
|
Australia |
|
16 |
USD 13.96 M
|
June 30, 2024 | USD 0.71 | 1.12% |
|
Australia |
|
17 |
USD 8.68 M
|
June 30, 2024 | USD 0.76 | 1.07% |
|
Australia |
|
18 |
USD 8.22 M
|
June 30, 2024 | USD 1.81 | -0.10% |
|
Australia |
|
19 |
USD 3.45 M
|
June 30, 2024 | USD 1.33 | 6.17% |
|
Australia |
|
20 |
USD -2.07 M
|
Dec. 31, 2023 | USD 1.27 | -1.68% |
|
Australia |
|
21 |
USD -4.59 M
|
June 30, 2024 | USD 2.00 | 1.52% |
|
Australia |
|
22 |
USD -13.05 M
|
June 30, 2024 | USD 3.31 | -4.06% |
|
Australia |
|
23 |
USD -13.57 M
|
June 30, 2024 | USD 0.62 | -2.68% |
|
Australia |
|
24 |
USD -17.85 M
|
June 30, 2024 | USD 1.53 | 1.32% |
|
Australia |
|
25 |
USD -18.50 M
|
June 30, 2024 | USD 1.77 | -1.67% |
|
Australia |
|
26 |
USD -25.42 M
|
June 30, 2024 | USD 0.74 | -1.40% |
|
Australia |
|
27 |
USD -29.70 M
|
June 30, 2024 | USD 1.93 | -0.52% |
|
Australia |
|
28 |
USD -29.77 M
|
June 30, 2024 | USD 2.37 | 1.84% |
|
Australia |
|
29 |
USD -45.56 M
|
Dec. 31, 2023 | USD 5.88 | 0.14% |
|
Australia |
|
30 |
USD -56.08 M
|
June 30, 2024 | USD 1.58 | -2.06% |
|
Australia |
|
31 |
USD -77.96 M
|
June 30, 2024 | USD 2.80 | 2.04% |
|
Australia |
|
32 |
USD -198.76 M
|
June 30, 2024 | USD 0.87 | 0.96% |
|
Australia |
|
33 |
USD -200.02 M
|
June 30, 2024 | USD 3.82 | 6.70% |
|
Australia |
The Health Care company in Australia with the highest EBITDA is CSL Limited (ASX: CSL.AX) at USD 4.73 B.
The Health Care company in Australia with the lowest EBITDA is Opthea Limited (NasdaqGS: OPT) at USD -200.02 M.
The top 10 Health Care companies in Australia by EBITDA are CSL Limited, Ramsay Health Care Limited, Sonic Healthcare Limited, Medibank Private Limited, EBOS Group Limited, Ansell Limited, Regis Healthcare Limited, Australian Clinical Labs Limited, Pro Medicus Limited and Viva Leisure Limited.
The bottom 10 Health Care companies in Australia by EBITDA are Opthea Limited, Healius Limited, Mayne Pharma Group Limited, Mesoblast Limited, Anteris Technologies Ltd, Clarity Pharmaceuticals Ltd, Immutep Limited, PYC Therapeutics Limited, Incannex Healthcare Limited and Kazia Therapeutics Limited.